Also known as: Vectibix; ABX-EGF
Panitumumab is a fully human monoclonal antibody that targets the epidermal growth factor receptor (EGFR), used in the treatment of metastatic colorectal cancer. Manufactured by Mediocon Inc in Aurangabad, Maharashtra, India at a GMP-certified facility. CAS No: 339177-26-3.
| Parameter | Specification |
|---|---|
| CAS Number | 339177-26-3 |
| Molecular Formula | Monoclonal antibody |
| Molecular Weight | ~147 kDa |
| Grade | IP / BP / EP / USP |
| Category | Monoclonal Antibody / EGFR Inhibitor / Antineoplastic |
| Appearance | Clear to slightly opalescent, colourless solution |
| Solubility | Supplied as solution for infusion |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2030 |
| Packing | 25 kg HDPE drums / as per requirement |